Sentante’s Endovascular Robot Enters Commercial Use in Vascular Surgery

Sentante has launched commercial use of its CE-marked endovascular robotic platform for vascular surgery and interventional radiology, three months after regulatory approval. The system uses standard catheters and records detailed procedural data to enable future AI-driven assistance in endovascular procedures.